AG百家乐大转轮-AG百家乐导航_怎么看百家乐走势_全讯网官网 (中国)·官方网站

Research News

The Signing Ceremony of Cooperative Agreement on “Collaborative Innovation Center for Personalized Prevention and Treatment of Four Common Malignant Tumors in China” Held in SYSU

Share
  • Updated: Aug 19, 2012
  • Written:
  • Edited:
Source: Office of Medical Science
Written by: Fan Ruiquan

On August 15, the signing ceremony of cooperative agreement on “Collaborative Innovation Center for Personalized Prevention and Treatment of Four Common Malignant Tumors in China” was held in SYSU. The Center is jointly established by Sun Yat-sen University Cancer Center (SYSUCC), Fudan University Shanghai Cancer Center (FUSCC), and Cancer Institute and Hospital, Chinese Academy of Medical Sciences “(CIHCAMS). Over 20 guests attended the signing ceremony including Xu Anlong, Vice President of Sun Yat-sen University, Li Jianchao, Secretary of SYSUCC Party Committee, Ma Jun, Deputy President of SYSUCC, Guo Xiaomao, President of FUSCC, and He Jie, President of CIHCAMS. The ceremony was moderated by Liang Dan, Director of the Office of Medical Science, Sun Yat-sen University.


The signing ceremony
 
According to the requirement of being “much-needed in the nation and first-class in the world”, the Collaborative Innovation Center for Personalized Prevention and Treatment of Four Common Malignant Tumors in China will develop collaborative innovations, aiming at the national important task of cancer prevention and treatment, putting together the advantageous resources of 5 state key laboratories in SYSUCC, FUSCC and CIHCAMS, centering on the scientific question of how to undertake personalized diagnosis and treatment effectively, enhancing the innovation capabilities of talents, discipline and research, and promoting the reform of mechanism and system. The Collaborative Innovation Center plans to cooperate on danger early warning model, molecular typing and personalized treatment of malignant tumors, and in about 10 years, build it into an academic highland of world-class cancer research, make China’s research on personalized diagnosis and treatment of the four malignant tumors (nasopharyngeal cancer, esophageal cancer, breast cancer and colon cancer) reach the advanced level in the world, increase early diagnosis rate and survival rate, reduce incidence and mortality, thus promoting the well-being of mankind.
TOP
百家乐官网赌注| 乐百家国际娱乐城| 博彩百家乐官网最新优惠| 百家乐投注网中国| 百家乐扑克玩法| 澳门百家乐网40125| 博盈| 百家乐官网赌博游戏平台| 百家乐官网游戏类型| 网上百家乐官网记牌软件| 362百家乐官网的玩法技巧和规则| 鑫鼎百家乐娱乐城| 砀山县| 网络百家乐官网必胜投注方法| 澳门百家乐会出千吗| 六合彩管家婆| 362百家乐官网的玩法技巧和规则| 百家乐如何盈利| 澳门百家乐官网单注下限| 百家乐投注网站是多少| 大发888娱乐场解码器| 迪威百家乐官网娱乐| 做生意摆放龙龟方向| 金龍百家乐的玩法技巧和规则 | 百家乐官网现场新全讯网| 百家乐桌子轮盘| 德州扑克起手牌概率| 百家乐官网新注册送彩金| 中原百家乐的玩法技巧和规则| TT百家乐官网现金网| 乐天百家乐官网的玩法技巧和规则| 百家乐下注法| 百家乐官网凯时娱乐平台| 百家乐园sun811| 机率游戏| 澳门百家乐官网www.bjbj100.com| 百家乐官网庄闲规则| 百家乐官网梅花图标| 大发888账号注册| 博彩百家乐官网组选六六组| 大发888下载安全的|